Adcis, Inc. is hiring
An opportunity to become our Developer Agent in Computer Vision
The French Ministry of Education and Research has reapproved ADCIS activities in the field of Research and Development, especially for its works in the fields of ophthalmology, Deep Learning, and point cloud for the years 2022 to 2024.
ADCIS was present at the SantExpo 2022 trade show in Paris in May 17-19 at the Evolucare group’s booth.
After being long-standing partners in the RetinOpTIC project and associates in OphtAI since 2019, ADCIS officially joined the Evolucare group on January 14th, 2022.
Large-scale pilot study of acceptability and efficiency in Normandy pharmacies to evaluate the benefit of an early screening of diabetic retinopathy in diabetic patients
Copyright © 2023 ADCIS SAS